Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLC
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if higher dose of bevacizumab can be taken safely by some
patients and if changes in the dose of bevacizumab have any effect on blood pressure.